scispace - formally typeset
I

Ik-Kyung Jang

Researcher at Harvard University

Publications -  427
Citations -  26768

Ik-Kyung Jang is an academic researcher from Harvard University. The author has contributed to research in topics: Myocardial infarction & Intravascular ultrasound. The author has an hindex of 73, co-authored 404 publications receiving 24255 citations. Previous affiliations of Ik-Kyung Jang include Katholieke Universiteit Leuven & Hospital General Universitario Gregorio Marañón.

Papers
More filters
Book ChapterDOI

The Development of OCT

TL;DR: This chapter reviews the early history of OCT development with an emphasis on basic concepts and the process of technology translation, as well as advances in imaging speed using swept source/Fourier domain detection.
Journal ArticleDOI

Clinical significance of healed plaque detected by optical coherence tomography: a 2-year follow-up study

TL;DR: Patients with healed plaque in the culprit vessel had a higher incidence of revascularization, as compared to those without healed plaque, at 2 years, and presence of layered plaque and low-density lipoprotein cholesterol levels were independently associated with an increased risk ofRevascularization.
Journal ArticleDOI

Lipid rich plaque, female gender and proximal coronary stent edge dissections.

TL;DR: OCT confirms that female gender is associated with a greater than twofold increased risk of developing proximal coronary edge dissections as compared to men and the most potent independent predictor of proximal artery edge dissection is the presence of a proximal lipid rich plaque.
Journal ArticleDOI

Near Infrared Spectroscopy Another Toy or Indispensible Diagnostic Tool

TL;DR: Although the factors for future cardiac events were identified, all 3 predictors are related to plaque burden, so radiofrequency intravascular ultrasound was used in the PROSPECT trial and showed that plaque burden >70%, virtual histology-thin–cap fibroatheroma, and minimal luminal area ≤4.0 mm2 are factors for composite major adverse cardiac events during the 3-year follow-up period.